This study is not accepting new patients
Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)
Summary
- Eligibility
- for people ages 2 years and up (full criteria)
- Location
- at UCLA
- Dates
- study started
- Principal Investigator
- by Shaun Hussain, MD (ucla)
Description
Summary
Details
Keywords
Eligibility
Location
Lead Scientist at University of California Health
- Shaun Hussain, MD (ucla)
Hs Clinical Professor, Pediatrics, Medicine. Authored (or co-authored) 45 research publications
Details
- Status
- not accepting new patients
- Start Date
- Sponsor
- University of California, Los Angeles
- ID
- NCT04437004
- Study Type
- Expanded Access
- Last Updated